Hinge receives FDA clearance for new migraine device
read at STAT ↗ApprovalPositive
Hinge announced that its migraine treatment device has received clearance from the U.S. Food and Drug Administration.
The clearance allows the company to market the device in the United States and signals regulatory acceptance of its technology, which is aimed at relieving migraine symptoms.
The news was reported in STAT’s Health Tech newsletter, which also covered other health‑technology updates.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Hinge has a new FDA-cleared migraine device”
read at STAT ↗441 words · retrieved Apr 30
comments(0)
5-min edit window · permanent after that